STAA STAAR Surgical Company logo

STAA STAAR Surgical Company

Healthcare
$32.47-0.98%ClosedMarket Cap: $1.62B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

4.60

P/S

5.57

EV/EBITDA

102.87

DCF Value

$1.39

FCF Yield

-3.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

76.4%

Operating Margin

-1.7%

Net Margin

-7.2%

ROE

-6.1%

ROA

-4.7%

ROIC

-1.3%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$93.5M$5.2M$
Q4 null$57.8M$-18.3M$
FY null$239.4M$-80.4M$
Q3 null$94.7M$8.9M$

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$29.54

Target (Median)

$31.00

Target Range

$13.00 - $40.00

0 Strong Buy3 Buy9 Hold0 Sell0 Strong Sell
Wells FargoEqual Weight
2026-05-15
WedbushOutperform
2026-05-14
MizuhoNeutral
2026-05-14
StifelHold
2026-05-14
Piper SandlerNeutral
2026-05-14

Trading Activity

Insider Trades

View All
Foust Warrenofficer: Interim Co-CEO and Pres. & COO
SellTue May 19
Foust Warrenofficer: Interim Co-CEO and Pres. & COO
SellTue May 19
Foust Warrenofficer: Interim Co-CEO and Pres. & COO
SellTue May 19
Foust Warrenofficer: Interim Co-CEO and Pres. & COO
SellTue May 19
ANDREWS DEBORAH Jofficer: Interim Co-CEO and CFO
SellTue May 19

Company Info

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Country

US

Exchange

Beta

1.20

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Peers